SI
IMGN

Stephens Inc’s Immunogen Inc IMGN Stock Holding History

Stephens Inc’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,780
Closed -$52K – 1252
2022
Q3 		$52K Sell
10,780
-3,946
-27% -$20.8K ﹤0.01% 1128
2022
Q2 		$66K Buy
14,726
+135
+0.9% +$586 ﹤0.01% 1150
2022
Q1 		$69K Sell
14,591
-2,893
-17% -$16K ﹤0.01% 1244
2021
Q4 		$130K Sell
17,484
-4,667
-21% -$29K ﹤0.01% 1243
2021
Q3 		$126K Sell
22,151
-1,820
-8% -$10.5K ﹤0.01% 1257
2021
Q2 		$158K Sell
23,971
-129
-0.5% -$900 ﹤0.01% 1232
2021
Q1 		$195K Sell
24,100
-3,146
-12% -$25.7K ﹤0.01% 1176
2020
Q4 		$176K Sell
27,246
-3,480
-11% -$20.3K ﹤0.01% 1099
2020
Q3 		$111K Sell
30,726
-701
-2% -$2.83K ﹤0.01% 1088
2020
Q2 		$145K Buy
31,427
+1,664
+6% +$7.08K ﹤0.01% 1020
2020
Q1 		$101K Buy
29,763
+180
+0.6% +$787 ﹤0.01% 978
2019
Q4 		$151K Buy
29,583
+1,781
+6% +$6.04K ﹤0.01% 1037
2019
Q3 		$67K Sell
27,802
-939
-3% -$2.49K ﹤0.01% 1120
2019
Q2 		$62K Sell
28,741
-1,647
-5% -$3.9K ﹤0.01% 1155
2019
Q1 		$82K Buy
30,388
+1,155
+4% +$5K ﹤0.01% 1134
2018
Q4 		$140K Buy
29,233
+707
+2% +$4.29K ﹤0.01% 1024
2018
Q3 		$270K Buy
+28,526
New +$274K 0.01% 956
2017
Q3 		– Sell
-38,429
Closed -$273K – 891
2017
Q2 		$273K Sell
38,429
-872
-2% -$3.99K 0.01% 710
2017
Q1 		$152K Buy
+39,301
New +$115K 0.01% 784

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Stephens Inc's IMGN Position: Q4 2022 in Review

Stephens Inc sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 10,780 shares — an estimated $52K sold.

Stephens Inc first reported a position in IMGN in Q1 2017 and held it in 19 quarters. The position peaked at $273K in Q2 2017. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • Stephens Inc reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • Stephens Inc sold 10,780 Immunogen Inc shares in Q4 2022, an estimated $52K.
  • Stephens Inc first reported a position in Immunogen Inc in Q1 2017 and held it in 19 quarters.
  • Stephens Inc's Immunogen Inc position peaked at $273K in Q2 2017.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Stephens Inc's 13F filing for Q4 2022, filed 25 Jan 2023.